|
The perpetrator of the Anthrax outbreak of 2001 has been identified by the FBI as Bruce Ivins. The conclusions presented here do not address the criminal investigation, but rather how public health officials dealt with the anthrax outbreak. |
The first
stage of addressing the American Anthrax Outbreak of 2001 has gone well. A deadly outbreak
was contained, limited to
America's East Coast, with few cases (22 initially counted, but perhaps only 18) and even fewer deaths. Yet while
minor in disease burden, the outbreak was large enough to show what a
clever and determined terrorist or group of terrorists could do to harm the
nation. Thus the outbreak served as a proof-in-concept, now established by a perverse mind or diabolic group.
SECOND STAGE (Disease Detective)
Details of how epidemiologists address outbreaks have been
described at this site, including writings of CDC, clinicians, the news media
and others. Clever and thorough detective work has identified the infected
cases, determined the mode of transmission, and clarified local conditions that
facilitate transmission. Eighteen cases were acquired through direct
contact with Anthrax spore-containing letters. Four were possibly infected
through contact with letters that earlier had been contact with spore-containing
envelopes. What has not yet occurred is finding the
perpetrator, a task better handled by criminal detectives, notably the Federal
Bureau of Investigation. While the Anthrax outbreak
was fearful in content and mysterious in scope, the process of puzzle-solving is similar
to other epidemiologic investigations.
THIRD STAGE (Health Educator)
The last stage is perhaps the most important since if done
well, many lives will be saved.
To
help educate the public, CDC epidemiologists during the Anthrax outbreak have
regularly presented their findings via their
website, held press conferences,
and actively involved both the print and electronic media as vehicles of
information and education. All of these educational vehicles are included at
this site. As a result of such efforts, the public has come to understand
the problem, physicians are aware of what to look for among patients, and
political leaders understand the importance of leadership, thoughtful
reflection, and decision-making to prevent future occurrences.
Cases. By the end of 2001, CDC had identified 22 cases as being part of the outbreak: 11 confirmed as cutaneous anthrax (4 suspected and 7 confirmed) and 11 as the more deadly inhalational anthrax. One person in the first week of December was excluded because he did fit the case definition, accounting for 22 rather than 23 cases, as appeared earlier in the outbreak. More cases are being searched for, with CDC identifying seven needing further evaluation. In March 2002, another case arose in a laboratory worker, contaminated while handling an anthrax specimen that came from the original mailings. This accidental laboratory case of cutaneous anthrax (addenda) is not considered by Professor Frerichs to be part of the outbreak.
Cross-contamination. Perhaps most intriguing in this final stage of the investigation are the potential cases of mail cross-contamination, being four (cases 4, 18, 22, 23). If anthrax-laden envelops could have been pushed or beat during the mail sorting and stamping process so that minute spores are transmitted to surrounding envelopes, then those going through the Trenton, New Jersey postal facility who come in contact with secondary envelopes around September 18 or October 9 might also be at risk. Or alternatively the risk could over a longer duration if the machines are contaminated, passing spores to mail that follows in the coming days or weeks.
How high is the risk? If the four mysterious cases are due to secondary transmission, then the numerator of the risk is 4. But what is the denominator? Possibly there were hundreds of thousands of envelops that came in contact with the seven or more envelops that held the spores. Could these envelopes be laying around households, still unread or untended?
The United States Postal Service has the means to trace envelops by bar-codes, but it is a time consuming and expensive undertaking, not to be done lightly. Thus before embarking on an expensive intervention, the Postal Service is awaiting confirmation on risk of cross-contamination from CDC. As of December 7, CDC has issued incriminating comments about cases 4 and 18, but still views cases 22 and 23 as mysteries. Thus no further action has yet being suggested for the Postal Service to undertake.
How will the situation be resolved? CDC on December 7, 2001 issued the following statement, taking into account the apparent low risk of cross-contamination: "Despite this very low risk (as documented), persons remaining concerned about their risk may want to take additional steps such as not opening suspicious mail; keeping mail away from your face when you open it and not blowing or sniffing mail or mail contents; washing your hands after you handle the mail; avoiding vigorous handling of mail, such as tearing or shredding mail before disposal; and discarding envelopes after opening mail. However, the effectiveness of these steps in reducing any residual risk is not known." They further recommend, "Suspicious persons or situations should be reported to law enforcement authorities. Health-care providers should remain alert for persons with clinical presentations consistent with early anthrax, obtain appropriate diagnostic tests (e.g., blood cultures and chest radiograph), and report suspicious illnesses to local or state public health authorities." Finally CDC concludes with a thought about deaths: "Fatalities can be minimized by promptly initiating combination antimicrobial therapy."
The health education stage continues.
Click for news account of hindsight analysis (1/6/02)
Click for Time magazine article on problems protecting the public's
health (1/14/02)
Click for
lessons learned in ensuing six months (3/26/02)
Click for
lessons learned in ensuing three years years (2005)